T-MAXIMUM Pharmaceutical (T-MAXIMUM) is a clinical-stage biotech company based in Suzhou, China focusing on the development of allogeneic universal CAR-T cell therapies for solid tumors. It’s core technology platform utilizes a fully proprietary gene-edited immuno-cellular therapy approach. This approach limits the risks of graft-versus-host disease and rejection, allowing allogeneic CAR-T cells persist within the patient's body for an extended period, thereby achieving optimal therapeutic effects with Best-in-Class potential. T-MAXIMUM is currently focusing on advanced-stage malignancies, with its lead pipeline product for recurrent high-grade glioma (rHGG) demonstrating breakthrough efficacy and manageable safety in initial clinical studies and obtained Orphan Drug Designation (ODD) from the US FDA.
| Website | http://www.t-maximum.com/ |
| Employees | 4 (2 on RocketReach) |
| Founded | 2017 |
| Address | 6760 Folsom Blvd, Sacramento, California 95819, US |
| Phone | +1 400-960-0652 |
| Industry | Biotechnology Research |
| Keywords | Car T Cell Therapy, Solid Tumor Treatment, Allogeneic Cell Therapy, Cancer Treatment, Cancer Immunotherapy, Cell Therapy Development, Oncology Therapeutics, Clinical Stage Biotech, Biotechnology, Immuno Oncology, Hematologic Malignancies, Targeted Therapy, Gene Therapy, Drug Development, Pharmaceutical Research, Biopharmaceutical, Oncolytic Viruses, Checkpoint Inhibitors, Proprietary Technology |
Looking for a particular T-MAXIMUM PHARMACEUTICAL employee's phone or email?
T-MAXIMUM PHARMACEUTICAL Questions
Xiaoyun Shang is the CEO of T-MAXIMUM PHARMACEUTICAL.
2 people are employed at T-MAXIMUM PHARMACEUTICAL.
T-MAXIMUM PHARMACEUTICAL is based in Sacramento, California.
Top T-MAXIMUM PHARMACEUTICAL Employees
-
Xiaoyun Shang
Chief Executive Officer at T-MAXIMUM PHARMACEUTICAL
Sacramento, CA, US1 -
James Chiu
Business Development Center Director at T-MAXIMUM PHARMACEUTICAL
Sacramento, CA, US
